The annual meeting of the American Society of Human Genetics is right around the corner, and the Labcyte team is looking forward to the festivities in Vancouver. The conference will run from October 18th to 22nd, bringing together more than 6,000 scientists for an unparalleled overview of the year’s progress in genetics and genomics.
SynBioBeta has quickly become one of the premier conferences for the synthetic biology community, and this event will take place in our neighborhood. The Labcyte team is looking forward to meeting everyone in San Francisco to discuss the latest advances in this rapidly evolving field.
Labcyte CTO and founder Richard Ellson narrates a new video produced by the team at Google to familiarize scientists with the company and our unique acoustic energy-based automated liquid handlers. “The Echo does what tips and pins cannot,” he says, noting that these instruments miniaturize reactions, save money on reagents, allow unprecedented flexibility, and speed up workflows.
Just how personalized is today’s personalized medicine? Krister Wennerberg, Labcyte customer and collaborator at Finland’s Institute for Molecular Medicine (FIMM) discussed the topic on Mendelspod, highlighting a novel way that his institute is combining different types of studies to make treatment more individualized.
State-of-the-art Echo Liquid Handling and Access Automation Workstation have been installed in the Cystic Fibrosis Foundation’s new 20,400 square foot research facility in Lexington, Mass, reports the Boston Business Journal. The lab’s 23 scientists are committed to speeding up the development of treatments for the disease, testing drugs using real CF cells. They are especially interested in finding treatments for the rarer gene mutations, since there is a lack of investment in this area at drug companies.
Next week is a busy one for the Labcyte team, with two great conferences taking place in Europe and the U.S.